November 22, 2021 Philippe Tinmouth Dear Phil:Executive Offer Letter • January 21st, 2022 • Pardes Biosciences, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledJanuary 21st, 2022 Company Industry JurisdictionPardes Biosciences, Inc, a Delaware corporation (the “Company”), is pleased to offer you employment pursuant to the terms of this Executive Offer Letter (the “Agreement”).
FIRST AMENDMENT TO EXECUTIVE OFFER LETTERExecutive Offer Letter • July 31st, 2024 • GENTHERM Inc • Motor vehicle parts & accessories
Contract Type FiledJuly 31st, 2024 Company IndustryThis FIRST AMENDMENT TO EXECUTIVE OFFER LETTER (this “Amendment”) is entered into as of February 5, 2024, by and between Vishnu Sundaram (“Executive”) and Gentherm Incorporated (“Gentherm” or the “Company”). Executive and Gentherm are referred to herein each as a “Party” and, collectively, as the “Parties.”
Re: Executive Offer LetterExecutive Offer Letter • June 4th, 2021 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJune 4th, 2021 Company Industry JurisdictionIntegral Medicines, Inc., a Delaware corporation (the “Company”), is pleased to offer you employment pursuant to the terms of this Executive Offer Letter (the “Agreement”).
NEW RELIC, INC. EXECUTIVE OFFER LETTERExecutive Offer Letter • February 7th, 2023 • New Relic, Inc. • Services-prepackaged software
Contract Type FiledFebruary 7th, 2023 Company IndustryThis offer letter (this “Agreement”) is entered into by and between Mark Dodds (“Executive”) and New Relic, Inc., a Delaware corporation (the “Company”), with an effective date of August 26, 2022.
PARDES BIOSCIENCES, INC AMENDMENT NO. 1 TO EXECUTIVE OFFER LETTERExecutive Offer Letter • December 30th, 2021 • Pardes Biosciences, Inc. • Pharmaceutical preparations
Contract Type FiledDecember 30th, 2021 Company IndustryThis Amendment No. 1 (the “Amendment”) dated as of December 23, 2020 to the Executive Offer Letter (the “Original Agreement”) dated September 21, 2020, is by and between Pardes Biosciences, Inc, a Delaware corporation (the “Company”), and Brian P. Kearney, PharmD (“Employee”). All capitalized terms used but not otherwise defined herein shall have the same meanings as set forth in the Original Agreement.
company letterhead]Executive Offer Letter • July 1st, 2024 • 3 E Network Technology Group LTD • Services-computer programming services
Contract Type FiledJuly 1st, 2024 Company Industry
AMENDMENT No. 1 TO EXECUTIVE OFFER LETTERExecutive Offer Letter • October 31st, 2017 • Petmed Express Inc • Retail-drug stores and proprietary stores
Contract Type FiledOctober 31st, 2017 Company IndustryThis Amendment No. 1 (“Amendment”) to the Offer Letter (“Offer Letter”) is entered into as of August 23, 2017 (the “Effective Date”) by and between PetMed Express, Inc. (“PetMed” or the “Company”) and Bruce S. Rosenbloom, Chief Financial Officer of PetMed (the “Executive”).
NEW RELIC, INC. EXECUTIVE OFFER LETTERExecutive Offer Letter • February 7th, 2023 • New Relic, Inc. • Services-prepackaged software
Contract Type FiledFebruary 7th, 2023 Company IndustryThis offer letter (this “Agreement”) is entered into by and between David Barter (references to “you” and “your”) and New Relic, Inc., a Delaware corporation (the “Company”), with an effective date of August 1, 2022.